The keratosis treatment market is projected to grow from USD 3.5 billion in 2026 to USD 6.6 billion by 2036, at a CAGR of 6.5%. Topical retinoids will dominate with a 36.0% market share, while actinic keratosis will lead the applications segment with a 58.0% share.